MedTrace Logo

Income Generation, Food and Nutrient Security for Improved Livelihoods and Health Outcomes Among HIV-Positive, Kenya

NCT07620197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-06-02

No results posted yet for this study

Summary

The goal of this trial is to evaluate whether cassava root and sesame seed granules combined with nutrition education can improve the nutritional status of HIV-seropositive adults. People living with HIV face food insecurity, and HIV also increases nutrient requirements and reduces nutrient intake, leading to weight loss, underweight, and impaired immune function, which worsens the situation, leading to increased deaths. The main question was:

Does improving food and nutrient security improve the livelihoods and health outcomes among people living with HIV Researchers compared cassava root and sesame (simsim) seed granules combined with nutrition education to nutrition education alone to see if it works to improve the nutritional status of HIV-positive underweight adults.

* Participants received 230g of cassava root-simsim seed granules daily, and one session of structured individual nutrition education monthly during every visit to the hospital, totaling to 5 sessions during the 16-week study period
* Participants were offered structured individual nutrition education monthly, totaling to 5 sessions during the study period
* Participants visited the hospital monthly for resupply and nutrition education
* They brought back any unused granules during hospital visits.

Conditions

  • HIV (Human Immunodeficiency Virus)
  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

Arm1 - Cassava root and (sesame) simsim seed granules

cassava-simsim granules

BEHAVIORAL

Nutrition education

Structured nutrition education

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Maseno University

    lead OTHER

Principal Investigators

  • Florence F Habwe, PhD · Maseno University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-11
Primary Completion
2024-11-29
Completion
2024-12-06

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07620197 on ClinicalTrials.gov